Minjiang Wang1, Ronghua Zhao, Wangen Wang, Xiaojian Mao, Jie Yu. 1. Level-3 Laboratory of State Administration of TCM of the People's Republic of China, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan Province, China.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Raw and processed Polygoni Multiflori Radix (PMR) are used in the prevention and treatment of non-alcoholic fatty liver disease (NAFLD), hyperlipidemia or related diseases. However, few researches compared the activities of raw and processed PMR on lipid metabolism regulation. Moreover, the active substances of Polygonum multiflorum are still not clearly elucidated. MATERIALS AND METHODS: In this research, a sensitive, accurate and rapid in vitro model, steatosis hepatic L02 cell, was applied to compare the relative activities of raw and processed PMR on lipid metabolism regulation. Furthermore, the lipid regulation activities of emodin, physcion and 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-d-glucoside (TSG) were evaluated. The steatosis L02 cells were obtained after cultured with 1% fat emulsion-10% fetal bovine serum (FBS)-RPMI 1640 medium for 48h. Contents of total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) in L02 cells are evaluated after exposure. RESULTS: The intracellular TG contents were increased from 16.50±1.29mmol/L to 34.40±1.36mmol/L in steatosis L02 cells, while the intracellular contents of TC were increased from 5.07±1.80mmol/L to 11.79±0.54mmol/L. Water extract of raw PMR showed much remarkable TG-regulation and TC-regulation effects than its processed products. Emodin displayed the best TG regulation activity while TSG showed the best TC regulation activity. At the same time, the exposure of emodin and physcion could reduce the LDL-C contents in steatosis L02 cells. CONCLUSIONS: On account of these in vitro results, raw PMR might have more satisfactory effects in clinic treatment of NAFLD or hyperlipidemia characterized by the elevation of cholesterol than processed PMR.
ETHNOPHARMACOLOGICAL RELEVANCE: Raw and processed Polygoni Multiflori Radix (PMR) are used in the prevention and treatment of non-alcoholic fatty liver disease (NAFLD), hyperlipidemia or related diseases. However, few researches compared the activities of raw and processed PMR on lipid metabolism regulation. Moreover, the active substances of Polygonum multiflorum are still not clearly elucidated. MATERIALS AND METHODS: In this research, a sensitive, accurate and rapid in vitro model, steatosis hepatic L02 cell, was applied to compare the relative activities of raw and processed PMR on lipid metabolism regulation. Furthermore, the lipid regulation activities of emodin, physcion and 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-d-glucoside (TSG) were evaluated. The steatosis L02 cells were obtained after cultured with 1% fat emulsion-10% fetal bovine serum (FBS)-RPMI 1640 medium for 48h. Contents of total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) in L02 cells are evaluated after exposure. RESULTS: The intracellular TG contents were increased from 16.50±1.29mmol/L to 34.40±1.36mmol/L in steatosis L02 cells, while the intracellular contents of TC were increased from 5.07±1.80mmol/L to 11.79±0.54mmol/L. Water extract of raw PMR showed much remarkable TG-regulation and TC-regulation effects than its processed products. Emodin displayed the best TG regulation activity while TSG showed the best TC regulation activity. At the same time, the exposure of emodin and physcion could reduce the LDL-C contents in steatosis L02 cells. CONCLUSIONS: On account of these in vitro results, raw PMR might have more satisfactory effects in clinic treatment of NAFLD or hyperlipidemia characterized by the elevation of cholesterol than processed PMR.
Authors: Min Chul Kho; Yun Jung Lee; Ji Hun Park; Jeong Dan Cha; Kyung Min Choi; Dae Gill Kang; Ho Sub Lee Journal: BMC Complement Altern Med Date: 2016-03-09 Impact factor: 3.659
Authors: Yan-Xu Chang; Ai-Hua Ge; Yan Jiang; John Teye Azietaku; Jin Li; Xiu-Mei Gao Journal: Evid Based Complement Alternat Med Date: 2016-01-26 Impact factor: 2.629
Authors: Pei Lin; Yan Ran He; Jian Mei Lu; Na Li; Wan Gen Wang; Wen Gu; Jie Yu; Rong Hua Zhao Journal: Evid Based Complement Alternat Med Date: 2014-04-30 Impact factor: 2.629